Table 4 Regression analysis for CI-AKI predictors after second agent

Interval time

0.033

1.170

1.980–2.370

0.037

Female

0.232

1.460

0.660–3.226

0.350

NYHA class II-III

0.056

1.381

0.576–3.309

0.469

Hypertension

0.064

2.107

0.929–4.774

0.074

Diabetes

0.135

1.296

0.582–2.888

0.526

Diuretics

0.012

1.268

0.489–3.288

0.625

CCB

0.743

1.329

0.601–2.939

0.482

β-RB

0.918

0.698

0.277–1.759

0.446

ACEI/ARB

0.166

0.428

0.191–0.958

0.039

Statins

0.106

4.203

0.809–21.846

0.088

Digitalis

0.006

1.291

0.453–3.677

0.632

IABP

0.001

3.302

1.055–10.335

0.040

LM lesion

0.164

0.880

0.356–2.177

0.782

Age

0.438

0.996

0.963–1.031

0.838

Basic SYNTAX score

0.083

1.006

0.952–1.063

0.838

CI-AKI post-first agent

< 0.001

3.454

1.278–9.333

0.015